$2.67T
Total marketcap
$49.7B
Total volume
BTC 49.91%     ETH 17.07%
Dominance

LadRx Corporation 0I5R.L Stock

1 USD {{ price }} -59.349594% {{change_pct}}%
Exchange
LSE
Market Cap
309.28K USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
18.9K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.355 USD

LadRx Corporation Price Chart

LadRx Corporation 0I5R.L Financial and Trading Overview

LadRx Corporation stock price 1 USD
Previous Close 7.78 USD
Open 0 USD
Bid 0 USD x N/A
Ask 0 USD x N/A
Day's Range 0 - 0 USD
52 Week Range 0 - 8 USD
Volume 1.52K USD
Avg. Volume 11.92K USD
Market Cap 2.16M USD
Beta (5Y Monthly) 2.011267
PE Ratio (TTM) N/A
EPS (TTM) -0.355 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0I5R.L Valuation Measures

Enterprise Value 3.64M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.84

Trading Information

LadRx Corporation Stock Price History

Beta (5Y Monthly) 2.011267
52-Week Change 6263.63%
S&P500 52-Week Change 20.43%
52 Week High 8 USD
52 Week Low 0 USD
50-Day Moving Average 1.05 USD
200-Day Moving Average 1.05 USD

0I5R.L Share Statistics

Avg. Volume (3 month) 11.92K USD
Avg. Daily Volume (10-Days) 7.48K USD
Shares Outstanding 33.64M
Float 381.54K
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 0.01:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -69.69%
Return on Equity (ttm) -368.40%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -4332090 USD
Net Income Avi to Common (ttm) -4403350 USD
Diluted EPS (ttm) -0.355
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 606.37K USD
Total Cash Per Share (mrq) 1.26 USD
Total Debt (mrq) 182.08K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.441
Book Value Per Share (mrq) -3.877

Cash Flow Statement

Operating Cash Flow (ttm) -4047169 USD
Levered Free Cash Flow (ttm) -2598448 USD

Profile of LadRx Corporation

Country United Kingdom
State CA
City Los Angeles
Address 11726 San Vicente Boulevard
ZIP 90049
Phone 310-826-5648
Website https://www.cytrx.com
Industry
Sector(s)
Full Time Employees 3

LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer. In addition, the company's Linker Activated Drug Release technology platform consists of an organic backbone, as well as develops albumin companion diagnostic to identify patients with cancer. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.

Q&A For LadRx Corporation Stock

What is a current 0I5R.L stock price?

LadRx Corporation 0I5R.L stock price today per share is 1 USD.

How to purchase LadRx Corporation stock?

You can buy 0I5R.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for LadRx Corporation?

The stock symbol or ticker of LadRx Corporation is 0I5R.L.

How many shares does LadRx Corporation have in circulation?

The max supply of LadRx Corporation shares is 309.28K.

What is LadRx Corporation Price to Earnings Ratio (PE Ratio)?

LadRx Corporation PE Ratio is now.

What was LadRx Corporation earnings per share over the trailing 12 months (TTM)?

LadRx Corporation EPS is -0.355 USD over the trailing 12 months.